ArticleNeoplasia (New York, N.Y.)2005

CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.

Sara Bar-Yehuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.